[REGN] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -1.65%
YoY- 50.20%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 1,582,447 1,500,673 1,470,116 1,318,991 1,226,827 1,220,122 1,212,629 19.35%
PBT 554,767 565,605 525,850 432,289 341,527 365,881 292,256 53.12%
Tax 381,248 177,288 138,106 183,358 88,412 101,077 96,038 150.08%
NP 173,519 388,317 387,744 248,931 253,115 264,804 196,218 -7.84%
Tax Rate -68.72% -31.34% -26.26% -42.42% -25.89% -27.63% -32.86% -
Total Cost 1,408,928 1,112,356 1,082,372 1,070,060 973,712 955,318 1,016,411 24.24%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 10.97 25.88 26.38 18.87 20.63 21.70 16.18 -22.76%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS 1.62 3.64 3.66 2.36 2.41 2.53 1.88 -9.42%
EPS Diluted 1.49 3.32 3.34 2.16 2.19 2.27 1.69 -8.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.